Biotechnology and artificial intelligence are transforming the future
The biotechnology industry is undergoing a radical digital transformation as artificial intelligence, cloud computing, and real-time analytics reshape the fields of drug discovery, personalized medicine, and healthcare delivery.
Revolutionary developments in AI drug discovery
Between March 31 and April 2, 2023, the Institute for Research in Biomedicine (IRB Barcelona) hosted the 43rd Barcelona Biomed Conference under the title “Artificial Intelligence in Drug Discovery and Biomedicine.” Leading scientists gathered to discuss revolutionary developments in employing artificial intelligence to advance drug discovery processes and develop personalized medicine.
Isomorphic Labs raises $600 million for AI-driven drug discovery
Isomorphic Labs, a spin-off from Google DeepMind, announced that it has successfully raised $600 million in new funding to accelerate its drug discovery efforts using artificial intelligence. This “Isomorphic Lab” represents a significant step toward the future of precision medicine.